drugset / Trial / NCT00532246

Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene or Placebo

NCT00532246

Phase 4 Completed 147 enrolled Eli Lilly and Company
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to measure carotid artery IMT at a single visit in a subset of women previously enrolled in the CORE (H3S-MC-GGJY) trial

Timeline

Start
2003-03
Primary completion
Completion
2003-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Raloxifene Other / unclassified